[ARNA] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ARNA] Arena Pharmaceuticals, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -38.75%
YoY- -161.82%
Quarter Report
ARNA's Result
ARNA's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 20 1,350 3,573 7,948 19,242 9,138 8,164 -63.25%
PBT -97,438 -72,865 -34,348 -32,673 -12,489 -26,390 -10,643 44.58%
Tax 2,484 7,673 3,079 929 -1,023 474 17,289 -27.60%
NP -97,438 -72,865 -34,314 -32,353 -12,357 -26,418 -10,672 44.52%
Tax Rate - - - - - - - -
Total Cost 97,458 74,215 37,887 40,301 31,599 35,556 18,836 31.48%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -487,190.00 -5,397.41 -960.37 -407.06 -64.22 -289.10 -130.72 293.26%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -1.69 -1.46 -0.70 -0.86 -0.51 -1.09 -0.49 22.89%
EPS Diluted -1.69 -1.46 -0.70 -0.86 -0.51 -1.09 -0.49 22.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.